Invention Grant
- Patent Title: Bupropion as a modulator of drug activity
-
Application No.: US14863284Application Date: 2015-09-23
-
Publication No.: US09278095B2Publication Date: 2016-03-08
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Brent A. Johnson
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K31/485 ; A61K31/138

Abstract:
This disclosure relates to methods administering bupropion or a prodrug thereof in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan or dextrorphan and bupropion or a prodrug of bupropion are also disclosed.
Public/Granted literature
- US20160008352A1 BUPROPION AS A MODULATOR OF DRUG ACTIVITY Public/Granted day:2016-01-14
Information query